Document Detail

Rosuvastatin-induced thrombocytopenia.
MedLine Citation:
PMID:  20531065     Owner:  NLM     Status:  MEDLINE    
Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature.
Ioannis Vrettos; Sotiris Papageorgiou; Christina Economopoulou; Vasiliki Pappa; Panagiotis Tsirigotis; Nikolaos Tountas; Theofanis Economopoulos; John Dervenoulas
Related Documents :
12022905 - Priapism associated with zuclopenthixol.
15196175 - Pemphigus vulgaris induced by radiotherapy.
8236465 - A prospective study of chloramphenicol induced aplastic anaemia in nigerians.
8913405 - Possible paroxetine-induced bruxism.
1456105 - Intracranial dermoid cysts with nasal dermal sinuses.
23573135 - Adverse events of acupuncture: a systematic review of case reports.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  103     ISSN:  1541-8243     ISO Abbreviation:  South. Med. J.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-30     Completed Date:  2010-07-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  676-8     Citation Subset:  AIM; IM    
Second Department of Internal Medicine, Propaedeutic, University of Athens, Medical School, Attikon University General Hospital, Haidari, Athens, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Dyslipidemias / drug therapy
Fluorobenzenes / adverse effects*,  therapeutic use
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*,  therapeutic use
Pyrimidines / adverse effects*,  therapeutic use
Sulfonamides / adverse effects*,  therapeutic use
Thrombocytopenia / chemically induced*,  diagnosis
Reg. No./Substance:
0/Fluorobenzenes; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Pyrimidines; 0/Sulfonamides; 287714-41-4/rosuvastatin
Comment In:
South Med J. 2010 Jul;103(7):602-3   [PMID:  20531042 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevalence of Acute Vasoresponsiveness in Patients With Pulmonary Hypertension: Treatment Implicatio...
Next Document:  Prevention of Needless Deaths From Drowning.